Incidence of Infusion Reactions by Treatment Cycle

Infusion-related reactions (IRRs) with GAZYVA (obinutuzumab) may be severe and life threatening, and can occur at any time 1

  • Symptoms may include hypotension, tachycardia, dyspnea, and respiratory symptoms (e.g., bronchospasm, larynx and throat irritation, wheezing, laryngeal edema)
  • Most frequently reported symptoms include nausea, fatigue, chest discomfort, dyspnea, dizziness, vomiting, diarrhea, constipation, rash, hypertension, hypotension, flushing, headache, pyrexia, and chills